Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center

BACKGROUND: Guidelines for optimal sequencing of radium-223 and chemotherapy for metastatic castration resistant prostate cancer (mCRPC) do not exist. This study evaluated treatment patterns and overall survival (OS) among patients with mCRPC treated with radium-223 in an academic clinical setting....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate Cancer Prostatic Dis
Main Authors: McKay, Rana R., Silver, Rebecca, Bhak, Rachel H., Korves, Caroline, Cheng, Mu, Appukkuttan, Sreevalsa, Simmons, Stacey J., Duh, Mei Sheng, Taplin, Mary-Ellen
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8012208/
https://ncbi.nlm.nih.gov/pubmed/32814846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41391-020-00271-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados